Generation of
free radicals during reperfusion after organ
ischemia has been implicated in the pathogenesis of ischemic injury. We have previously shown that a combination of intravenous
polyethylene glycol-conjugated
superoxide dismutase (
PEG-SOD) and
catalase (
PEG-CAT), at a dose of 10,000 U/kg each, is effective in reducing
infarct size in a focal
cerebral ischemia model in the rat. It is not clear whether
PEG-SOD alone is sufficient to reduce ischemic
brain injury. In this study we determined the therapeutic efficacy of
PEG-SOD and its dose-response curve. In a range of 1,000-30,000 U/kg,
PEG-SOD exhibited a U-shaped dose-response curve. Only 10,000 U/kg significantly reduced
infarct size [control 121 +/- 12 mm3 (mean +/- SE), n = 35;
PEG-SOD 95 +/- 10 mm3, n = 36, P < 0.05].
PEG-SOD at the doses tested did not have significant acute hemodynamic effects but had a tendency to improve postischemic
hypotension. This beneficial effect of
PEG-SOD on blood pressure did not appear to fully account for the treatment effect of
PEG-SOD on
infarct size. The narrow therapeutic dose range of
PEG-SOD in this study and similar findings of SOD in other investigations may contribute to the inconsistent protective effects of SOD preparations in
ischemia-reperfusion injury in the literature.